 | U.S. Probes Drugmakers Over Free Services
www.wsj.com - September 21 at 2:15 PM |
 | Molecular Templates Surges 50%, Inks Cancer Deal With Takeda
finance.yahoo.com - September 20 at 3:02 PM |
 | Novartis $372000 Cancer Drug Hits First Hurdle in Europe
www.bloomberg.com - September 19 at 3:09 PM |
| Viking Therapeutics Liver Candidate Passes Test, Shares Soar
finance.yahoo.com - September 19 at 3:09 PM |
| Is Gilead (GILD) a Suitable Stock for Value Investors Now?
finance.yahoo.com - September 19 at 3:09 PM |
| Gilead Faces Doubts on Wall Street a Year After $12 Billion Deal
finance.yahoo.com - September 19 at 3:09 PM |
| Biotech Stock Roundup: CELG, REGN Present Data, VKTX Soars on Drug's Success
finance.yahoo.com - September 19 at 3:09 PM |
| Agenus Receives Milestone Payment of $5 Million from Incyte
finance.yahoo.com - September 19 at 6:31 AM |
| UK rejects adult Novartis CAR-T therapy, after 'yes' in kids
finance.yahoo.com - September 19 at 6:31 AM |
 | Health Care Digest: UCSF's ImmunoX revolution, Gilead's deal, a pain breakthrough and more
www.bizjournals.com - September 18 at 3:17 PM |
 | Gilead: Forming A Base?
seekingalpha.com - September 18 at 3:17 PM |
| Viking Therapeutics and Madrigal Pharmaceuticals Are Racing to the Finish Line in NASH
finance.yahoo.com - September 18 at 3:17 PM |
| The Funded: Two big shutdowns, 3 IPO filings and a Walmart acquisition
www.bizjournals.com - September 18 at 5:04 AM |
| 3 High-Quality Biotech Companies for 4th Quarter
finance.yahoo.com - September 18 at 5:04 AM |
| Health Care Digest: UCSF's ImmunoX revolution, Gilead's deal, a pain breakthrough and more
finance.yahoo.com - September 18 at 5:04 AM |
| Should Value Investors Pick Gilead Sciences (GILD) Stock?
finance.yahoo.com - September 17 at 3:06 PM |
 | Why Gilead Stock Is a Sleepy Giant Waiting to Break Out
www.msn.com - September 17 at 3:06 PM |
 | FY2021 EPS Estimates for Gilead Sciences, Inc. (GILD) Raised by Analyst
www.americanbankingnews.com - September 17 at 2:20 AM |
| Gilead Sciences, Inc. (GILD) Expected to Announce Quarterly Sales of $5.38 Billion
www.americanbankingnews.com - September 15 at 1:36 AM |
| Unity (UBX) Catches Eye: Stock Jumps 8.8%
finance.yahoo.com - September 14 at 3:11 PM |
 | Fish & Richardson Principals Chad Shear and Jonathan Singer Named "2018 Winning Litigators" by The National Law Journal
www.prnewswire.com - September 14 at 12:33 PM |
 | A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis
www.fool.com - September 14 at 7:28 AM |
| How Gilead Call Prices Tripled Overnight
finance.yahoo.com - September 14 at 5:09 AM |
| Gilead taps Durham gene editing firm for $445M deal
finance.yahoo.com - September 14 at 5:09 AM |
| Analysts Anticipate Gilead Sciences, Inc. (GILD) Will Announce Earnings of $1.62 Per Share
www.americanbankingnews.com - September 13 at 10:16 PM |
| What's Next for Gilead Sciences After Its Latest Clinical Success
www.msn.com - September 13 at 3:07 PM |
| Gilead Inks Gene Editing Collaboration Deal for HBV Infection
finance.yahoo.com - September 13 at 3:07 PM |
| Company News For Sep 13, 2018
finance.yahoo.com - September 13 at 3:07 PM |
| Better Buy: Gilead Sciences, Inc. vs. Biogen
finance.yahoo.com - September 13 at 3:07 PM |
| Why Analysts Remain Bullish on Sangamo Therapeutics
finance.yahoo.com - September 13 at 3:07 PM |
| Sangamo Therapeutics: The Promise of Zinc Fingers
finance.yahoo.com - September 13 at 3:07 PM |
 | Gilead (GILD), Galapagos (GLPG) Announce Filgotinib Met Primary and All Key Secondary Endpoints in First Phase 3 Study in RA
www.streetinsider.com - September 13 at 5:11 AM |
| Why Gilead, Galapagos Shares Are Trading Higher
www.msn.com - September 13 at 5:11 AM |
 | Gilead's Rheumatoid Arthritis Drug Successful in Phase III
www.zacks.com - September 12 at 3:09 PM |
 | Gilead Sciences Inc. (GILD) Is Rising On Phase 3 Study Results
www.nasdaq.com - September 12 at 3:09 PM |
| Gilead Sciences (GILD) Reports Collaboration with Precision BioSciences to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing
www.streetinsider.com - September 12 at 3:09 PM |
| Why Gilead Is Banking Big on Hepatitis B and Rheumatoid Arthritis
www.msn.com - September 12 at 3:09 PM |
| 3 Top Stocks for Investing in Pharma's Next $35 Billion Market
finance.yahoo.com - September 12 at 3:09 PM |
| Incyte, Foundation Medicine Partner for Companion Diagnostics
finance.yahoo.com - September 12 at 3:09 PM |
| US STOCKS-Wall St to open flat as trade worries linger; Apple event in focus
finance.yahoo.com - September 12 at 3:09 PM |
| US STOCKS-Tech stocks weigh on Wall St, energy stocks help cut losses
finance.yahoo.com - September 12 at 3:09 PM |
| Merck's Antibacterial Drug Succeeds in Label Expansion Study
finance.yahoo.com - September 12 at 3:09 PM |
| Galapagos, Gilead bask in $4-6 billion new drug sales hope
finance.yahoo.com - September 12 at 3:09 PM |
| Biotech Stock Roundup: GILD's Arthritis Drug Successful in Phase III, PRQR Soars
finance.yahoo.com - September 12 at 3:09 PM |
| Here's Why Galapagos NV Is Skyrocketing 18.3% Today
finance.yahoo.com - September 12 at 3:09 PM |
| Piper Jaffray Companies Analysts Give Gilead Sciences (GILD) a $85.00 Price Target
www.americanbankingnews.com - September 12 at 10:42 AM |
| Gilead Sciences Reports Market-Moving News
finance.yahoo.com - September 12 at 8:40 AM |
| Gilead Sciences Brings Strong Rheumatoid Arthritis Data, This Train Keeps Rolling
seekingalpha.com - September 12 at 5:04 AM |
| Drug succeeds in arthritis study, Gilead stock jumps
finance.yahoo.com - September 12 at 5:04 AM |
| Ex-Dividend Reminder: El Paso Electric, DTE Energy and Gilead Sciences
www.nasdaq.com - September 11 at 3:06 PM |
